Open AccessCelecoxib Decreases Gcf Prostaglandin E2 Levels in Chronic Periodontitis Patients
Author(s) -
Athena Papas
Publication year - 2020
Publication title -
dentistry oral health and cosmesis
Language(s) - English
Resource type - Journals
ISSN - 2473-6783
DOI - 10.24966/dohc-6783/100012
Subject(s) - celecoxib , prostaglandin e2 , chronic periodontitis , scaling and root planing , periodontology , medicine , periodontitis , prostaglandin , dentistry , mediator
Prostaglandin E2 (PGE2) is a key mediator associated with periodontal bone loss. We recently demonstrated (Yen, et al, J Periodontology 79:104, 2008) that adjunctive use of Celecoxib (a COX-2 selective inhibitor) in conjunction with Scaling and Root Planning (SRP) resulted in significant reduction in Pocket Depth (PD) and gain in Clinical Attachment (CAL) in Chronic Periodontitis (CP) patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom